Are you Dr. Gellad?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Brigham Internal Medicine Associates
Boston, MA 02115Phone+1 617-732-6040
Summary
- Dr. Walid Gellad, MD is an internist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Pennsylvania. He is affiliated with Veterans Affairs Medical Center (Pittsburgh).
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
- University of Maryland School of MedicineClass of 2002
Certifications & Licensure
- PA State Medical License 2008 - 2024
- MA State Medical License 2004 - 2009
Publications & Presentations
PubMed
- 20 citationsInitial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in HistoryAhmad Masri, Hongya Chen, Catherine Wong, Katherine L. Fischer, Chafic Karam
JAMA Cardiology. 2020-06-17 - 115 citationsEvaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid PrescriptionsWei-Hsuan Lo-Ciganic, James L. Huang, Hao Helen Zhang, Jeremy C. Weiss, Yonghui Wu
JAMA Network Open. 2019-03-01 - 60 citationsCoverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare P...Jing Luo, Robert G. Feldman, Scott D. Rothenberger, Inmaculada Hernandez, Walid F. Gellad
JAMA Network Open. 2020-10-01
Authored Content
- Drug Prices, Rebates, and Discounts—ReplyJuly 2020
- Drug Prices, Rebates, and Discounts—ReplyJuly 2020
Press Mentions
- Experts See Lessons for Next Pandemic as Covid Emergency Comes to an EndMay 11th, 2023
- Paxlovid’s Rebound Rate Is 14%, According to StudyFebruary 24th, 2023
- Paxlovid Rebound Rate Is 14%, Study FindsFebruary 24th, 2023
- Join now to see all